High doses of vitamin KI map prove helpful to avoid fractures and cancer in postmenopausal women with osteopenia, but it doesn’t seem to prevent a decline in age-related bone mineral density, a new study suggests.

The study has been published in Journal of PLOS Medicine, weekly issue and it was the project of the University of Toronto. The researchers included 440 postmenopausal women with osteopenia that is a mild condition that occurs before osteoporisis. These women were given either 5 mg of vitamin KI or a placebo daily for two years.

Read the rest of this entry